- Case report
- Open Access
- Open Peer Review
Obstructive jaundice secondary to pancreatic head adenocarcinoma in a young teenage boy: a case report
© Brahmi et al; licensee BioMed Central Ltd. 2011
- Received: 14 February 2010
- Accepted: 6 September 2011
- Published: 6 September 2011
Pancreatic adenocarcinoma is extremely rare in childhood. We report a case of metastatic pancreatic adenocarcinoma in a 13-year-old boy, revealed by jaundice.
A 13-year-old Moroccan boy was admitted with obstructive jaundice to the children's Hospital of Rabat, Department of Pediatric Oncology. Laboratory study results showed a high level of total and conjugated bilirubin. Computerized tomography of the abdomen showed a dilatation of the intra-hepatic and extra-hepatic bile ducts with a tissular heterogeneous tumor of the head of the pancreas and five hepatic lesions. Biopsy of a liver lesion was performed, and a histopathological examination of the sample confirmed the diagnosis of metastatic ductal adenocarcinoma of the pancreas. Our patient underwent a palliative biliary derivation. After that, chemotherapy was administered (5-fluorouracil and epirubicin), however no significant response to treatment was noted and our patient died six months after diagnosis.
Malignant pancreatic tumors, especially ductal carcinomas, are exceedingly rare in the pediatric age group and their clinical features and treatment usually go unappreciated by most pediatric oncologists and surgeons.
- Pancreatic Adenocarcinoma
- Obstructive Jaundice
- Pediatric Oncologist
- Acinar Cell Carcinoma
Pancreatic tumors in childhood most commonly present with a palpable mass or with pain . Jaundice occurs much less commonly than in adults . Tumors of the pancreas can arise from exocrine or endocrine cells. The following tumor types are described in children and adolescents: ductal adenocarcinoma, acinar cell carcinoma, pancreatoblastoma, solid pseudopapillary tumor, and pancreatic endocrine neoplasms (benign and malignant) . In addition, there are reported cases of other tumor types, which either arise within the mass of the pancreas from other non-pancreatic cell types or immediately adjacent to it or involve the gland secondarily. Classic ductal adenocarcinoma of the pancreas, the common type in adults, is extremely rare in childhood. Most cases are in older literature. To examine the incidence trends and outcomes for children with pancreatic malignancies, the Surveillance, Epidemiology, and End Results Registry (1973 to 2004) was examined for pediatric patients with pancreatic malignancies (up to 19 years of age) . Malignant pancreatic neoplasms were identified in 58 patients. Women outnumbered men 1.9:1 (38 versus 20) for an age population-adjusted incidence of 0.021 and 0.015 per 100,000. Ductal adenocarcinoma, was identified in seven patients. A 90-year (1918 to 2007), single institution, retrospective review of all patients with neoplastic pancreatic masses was performed and published recently . Eighteen patients were identified with seven distinct histopathological subtypes. The most common were gastroenteropancreatic neuroendocrine, solid pseudopapillary, and acinar tumors. There were 6 benign and 12 malignant tumors. Surgery remains the keystone of treatment for pancreatic tumors in the pediatric age group, as in adults . Long-term disease-free survival in childhood pancreatic malignancies is achievable with complete surgical resection . There is no proven role for chemotherapy or radiation . The information available in the literature, particularly with regard to the role of chemotherapy and radiation, is anecdotal . These modalities should be reserved in unresectable and metastatic disease. Finally, it appears that ductal adenocarcinoma has a worse prognosis. According to a recent study, there was a significant difference in tumor type 15-year survival with ductal adenocarcinoma having the worst (23%) and solid cystic tumor the best (100%) .
Malignant pancreatic tumors especially ductal carcinomas are exceedingly rare in the pediatric age group and their clinical features and treatment usually go unappreciated by most pediatric oncologists and surgeons.
Written informed consent was obtained from the patient's next-of-kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Andiran F, Tanyel FC, Kale G, Akhan O, Akçören Z, Hiçsönmez A: Obstructive jaundice resulting from adenocarcinoma of the ampulla of vater in an 11-year-old boy. J Pediatr Surg. 1997, 4: 636-637.View ArticleGoogle Scholar
- Jaksic T, Yaman M, Thorner P, Wesson DK, Filler RM, Shandling B: A 20-year review of pediatric pancreatic tumors. J Pediatr Surg. 1992, 27: 1315-1317. 10.1016/0022-3468(92)90284-E.View ArticlePubMedGoogle Scholar
- Lack EE, Cassady JR, Levey R, Vawter GF: Tumors of the exocrine pancreas in children and adolescents: a clinical and pathologic study of eight cases. Am J Surg Pathol. 1983, 7: 319-327. 10.1097/00000478-198306000-00003.View ArticlePubMedGoogle Scholar
- Shorter NA, Glick RD, Klimstra DS, Brennan MF, Laquaglia MP: Malignant pancreatic tumors in childhood and adolescence: the Memorial Sloan-Kettering experience, 1967 to present. J Pediatr Surg. 2002, 37: 887-892. 10.1053/jpsu.2002.32897.View ArticlePubMedGoogle Scholar
- Perez EA, Gutierrez JC, Koniaris LG, Neville HL, Thompson WR, Sola JE: Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients. J Pediatr Surg. 2009, 44: 197-203. 10.1016/j.jpedsurg.2008.10.039.View ArticlePubMedGoogle Scholar
- Yu DC, Kozakewich HP, Perez-Atayde AR, Shamberger RC, Weldon CB: Childhood pancreatic tumors: a single institution experience. J Pediatr Surg. 2009, 44: 2267-2272. 10.1016/j.jpedsurg.2009.07.078.View ArticlePubMedGoogle Scholar
- Dall'igna P, Cecchetto G, Bisogno G, Conte M, Chiesa PL, D'Angelo P, De Leonardis F, De Salvo G, Favini F, Ferrari A, TREP Group: Pancreatic tumors in children and adolescents: the Italian TREP project experience. Pediatr Blood Cancer. 2010, 54: 675-680.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.